<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Chapter 8G. Prescription Drug Monitoring. | D.C. Law Library</title>
    <link rel="shortcut icon" href="/us/dc/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/dc/council/code/titles/48/chapters/8G/index.full.html"/>
    <meta itemprop="toc-json" content="/us/dc/council/code/titles/48/chapters/8G/index.json"/>
    <meta itemprop="parent-doc-url" content="/us/dc/council/code"/>
    <meta itemprop="order" content="|48|8G|"/>
    <meta itemprop="doc-type" content="container"/>
    <meta itemprop="ref-doc" content="D.C. Code"/>
    <meta itemprop="ref-path" content="48|8G"/>
    <!--OpenGraph-->
    <meta property="og:url" content="https://code.dccouncil.us/us/dc/council/code/titles/48/chapters/8G"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Chapter 8G. Prescription Drug Monitoring. | D.C. Law Library"/>
    <meta property="og:image" content="https://code.dccouncil.us/us/dc/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="msapplication-config" content="/browserconfig.xml"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#000000"/>
    <meta name="apple-mobile-web-app-title" content="D.C. Law Library"/>
    <meta name="theme-color" content="#000000"/>
    <meta name="msapplication-navbutton-color" content="#000000"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/dc/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/dc/_document/v2/images/favicons/safari-pinned-tab.svg" color="#000000"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/dc/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/dc/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/dc/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/dc/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet"/>
    <link href="/us/dc/_document/v2/fonts/droid-serif/droid-serif.css" type="text/css" rel="stylesheet"/>
    <link href="/us/dc/_document/v2/fonts/open-sans/open-sans.css" type="text/css" rel="stylesheet"/>
    <!--Document CSS-->
    <link href="/us/dc/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen"/>
    <link href="/us/dc/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen"/>
    <link href="/us/dc/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print"/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js"> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/dc/council/code/titles/48/chapters/8G/index.full.html" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__us-dc">
      <header id="section__header" class="ns__document__us-dc">
        <div id="section__header__inner" class="ns__document__us-dc">
          <div id="area__logo" class="ns__document__us-dc">
            <a href="/" class="logo" aria-label="Logo - Return to home page">
              <img src="/us/dc/_document/v2/images/logo/dc-seal-outline.png" srcset="/us/dc/_document/v2/images/logo/dc-seal-outline.png 1x, /us/dc/_document/v2/images/logo/dc-seal-outline@2x.png 2x" alt="Council of the District of Columbia logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__us-dc">
            <img src="/us/dc/_document/v2/images/logo/dccouncil_typemark.svg" srcset="" alt="D.C. Law Library"/>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__us-dc">
        <div id="section__content__inner" class="ns__document__us-dc">
          <section id="area__breadcrumbs" class="ns__document__us-dc" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="D.C. Law Library">D.C. Law Library</a>
                </li>
                <li data-search-path="library|D.C. Code" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/dc/council/code" title="Code of the District of Columbia">Code of the District of Columbia</a>
                </li>
                <li data-search-path="library|D.C. Code|48" data-search-heading="">
                  <a href="/us/dc/council/code/titles/48" title="Title 48. Foods and Drugs.">Title 48. Foods and Drugs.</a>
                </li>
                <li data-search-path="library|D.C. Code|48|8G" data-search-heading="">
                  <span title="Chapter 8G. Prescription Drug Monitoring.">Chapter 8G. Prescription Drug Monitoring.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__us-dc">
            <div class="h__document-title">Code of the District of Columbia</div>
            <article class="content" role="document" data-ref-path="48|8G">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/dc/council/code/titles/48/chapters/8G">Chapter 8G. Prescription Drug Monitoring.</h1>
                <h2 id="/us/dc/council/code/sections/48-853.01" data-order="|48|8G|48-853.01|" data-ref-path="§48-853.01" class="h__section">§ 48–853.01. Definitions.</h2>
                <p>For the purposes of this chapter, the term:</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(1)">(1)</span> “Administer” shall have the same meaning as provided in <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-901.02#(1)" title="">§ 48-901.02(1)</a>.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(2)">(2)</span> “Controlled substance” shall have the same meaning as provided in <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-901.02#(4)" title="">§ 48-901.02(4)</a>.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(3)">(3)</span> “Controlled Substances Act” means Unit A of <a class="internal-link " href="/us/dc/council/code/titles/48/chapters/9" title="Chapter 9. Controlled Substances Act.">Chapter 9 of this title</a> [<a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-901.01" title="§ 48–901.01. [Reserved].">§ 48-901.01</a> et seq.].</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(4)">(4)</span> “Covered substance” means all controlled substances included in the schedules set forth in §§ <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-902.06" title="§ 48–902.06. Schedule II enumerated.">48-902.06</a>, <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-902.08" title="§ 48–902.08. Schedule III enumerated.">48-902.08</a>, <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-902.10" title="§ 48–902.10. Schedule IV enumerated.">48-902.10</a>, and <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-902.12" title="§ 48–902.12. Schedule V enumerated.">48-902.12</a>, in schedules II through V of section 202(c) of Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, approved October 27, 1970 (84 Stat. 1247; 21 U.S.C. § 812), and any other drug, as specified by rulemaking, that is required to be reported to the Prescription Drug Monitoring Program pursuant to this chapter.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(5)">(5)</span> “Department” means the Department of Health.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(6)">(6)</span> “Director” means the Director of the Department of Health.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(7)">(7)</span> “Dispense” shall have the same meaning as provided in <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-901.02#(7)" title="">§ 48-901.02(7)</a>.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(8)">(8)</span> “Dispenser” means a practitioner who dispenses a covered substance to the ultimate user, or his or her agent, but shall not include:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(8)(A)">(A)</span> A licensed hospital or institutional facility pharmacy that distributes covered substances for the purpose of inpatient hospital care or the dispensing of prescriptions for controlled substances at the time of discharge from such a facility;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(8)(B)">(B)</span> A practitioner or other authorized person who administers a covered substance;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(8)(C)">(C)</span> A wholesale distributor of a covered substance; or</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(8)(D)">(D)</span> A clinical researcher providing a covered substance to research subjects as part of a research study approved by a hospital-based institutional review board or an institutional review board accredited by the association for the accreditation of human research protections programs.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(9)">(9)</span> “Drug” means:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(9)(A)">(A)</span> Any substance recognized as a drug, medicine, or medicinal chemical in the official United States Pharmacopoeia, official National Formulary, official Homeopathic Pharmacopoeia, or official Veterinary Medicine Compendium or other official drug compendium or any supplement to any of them;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(9)(B)">(B)</span> Any substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animal;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(9)(C)">(C)</span> Any chemical substance, other than food, intended to affect the structure or any function of the body of man or other animal; and</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(9)(D)">(D)</span> Any substance intended for use as a component of any items specified in subparagraph (A), (B), or (C) of this paragraph, but does not include medical devices or their components, parts, or accessories.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(10)">(10)</span> “Health occupations board” means a board that, pursuant to <a class="internal-link no-wrap" href="/us/dc/council/code/sections/3-1204.08" title="§ 3–1204.08. General powers and duties.">§ 3-1204.08</a>, licenses and regulates health professionals with the authority to prescribe or dispense covered substances.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(11)">(11)</span> “Interoperability” means, with respect to a District of Columbia or state prescription drug monitoring program, the ability of that program to share electronically reported prescription information with another state, district, or territory of the United States’ prescription drug monitoring program or a third party, approved by the Director, that operates interstate prescription drug monitoring exchanges.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(12)">(12)</span> “Patient” means the person or animal who is the ultimate user of a controlled substance or other drug required to be submitted under this chapter for whom a lawful prescription is issued or for whom a controlled substance or such other drug is lawfully dispensed.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(13)">(13)</span> “Practitioner” shall have the same meaning as provided in <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-901.02#(20)" title="">§ 48-901.02(20)</a>.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(14)">(14)</span> “Prescriber” means a practitioner or other authorized person who prescribes a controlled substance or other covered substance in the course of his or her professional practice.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(15)">(15)</span> “Prescription drug monitoring program” means a program that collects, manages, analyzes, and provides information regarding covered substances or other drugs required to be submitted under this chapter or a program established by a similar act in another state, district, or territory of the United States.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(16)">(16)</span> “Program” means the Prescription Drug Monitoring Program established by <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-853.02" title="§ 48–853.02. Program establishment; Director’s authority.">§ 48-853.02</a>.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.01#(17)">(17)</span> “Ultimate user” shall have the same meaning as provided in <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-901.02#(23)" title="">§ 48-901.02(23)</a>.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66#§2" title="§ 2.">Feb. 22, 2014, D.C. Law 20-66, § 2, 61 DCR 7</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.02" data-order="|48|8G|48-853.02|" data-ref-path="§48-853.02" class="h__section">§ 48–853.02. Program establishment; Director’s authority.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.02#(a)">(a)</span> There is established the Prescription Drug Monitoring Program within the Department. The Program shall:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.02#(a)(1)">(1)</span> Establish, maintain, and administer an electronic system to monitor the dispensing of covered substances;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.02#(a)(2)">(2)</span> Provide dispensers with a basic file layout to enable electronic transmission of the information required under this chapter; and</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.02#(a)(3)">(3)</span> Establish and maintain a process for verifying the credentials of and authorizing the use of prescription information by those individuals and agencies listed in <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-853.05#(b)" title="">§ 48-853.05(b)</a> and (c).</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.02#(b)">(b)</span> The Director may contract with another District agency or a private vendor as may be necessary for the implementation and maintenance of the Program. Any such contractor shall be bound to comply with the provisions regarding confidentiality of data in this chapter and shall be subject to the penalties specified in this chapter.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.02#(c)">(c)</span> The Director shall also establish a multi-discipline advisory committee, which shall function under the Department to assist in the implementation and evaluation of the Program.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66#§3" title="§ 3.">Feb. 22, 2014, D.C. Law 20-66, § 3, 61 DCR 7</a>.)
    </p>
                  <h4>Section References</h4>
                  <p>This section is referenced in <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-853.01" title="§ 48–853.01. Definitions.">§ 48-853.01</a>.</p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.03" data-order="|48|8G|48-853.03|" data-ref-path="§48-853.03" class="h__section">§ 48–853.03. Reporting requirements; exceptions.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(a)">(a)</span><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(a)(1)">(1)</span> Each dispenser shall submit to the Program the required reporting information for each prescription dispensed for a covered substance within 24 hours after the covered substance is dispensed, unless otherwise established by the Director through rulemaking, but this does not include merely placing the covered substance prescription into a bin for pickup by the ultimate user or his or her agent.</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(a)(2)">(2)</span> Any dispenser located outside the boundaries of the District that is licensed or registered by the District, shall submit the required reporting information to the Program for each prescription dispensed for a covered substance to an ultimate user who resides within the District within 24 hours after the date that the covered substance is dispensed, unless otherwise established by the Director through rulemaking.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(b)">(b)</span> The failure of any person subject to the reporting requirements of this chapter to report the dispensing of a covered substance, unless otherwise exempted under this chapter, or the willful failure to transmit accurate information shall constitute grounds for:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(b)(1)">(1)</span> The revocation, suspension, or denial of a District controlled substances registration;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(b)(2)">(2)</span> Disciplinary action by the relevant health occupations board pursuant to <a class="internal-link no-wrap" href="/us/dc/council/code/sections/3-1205.14#(c)" title="">§ 3-1205.14(c)</a>; and</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(b)(3)">(3)</span> The imposition of civil fines pursuant to <a class="internal-link no-wrap" href="/us/dc/council/code/sections/2-1801.04" title="§ 2–1801.04. Monetary sanctions.">§ 2-1801.04</a>.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)">(c)</span> Upon dispensing a covered substance, the dispenser of the covered substance shall report the following information to the Program:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(1)">(1)</span> Patient name;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(2)">(2)</span> Patient address;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(3)">(3)</span> Patient date of birth;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(4)">(4)</span> Patient gender;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(5)">(5)</span> Dispenser identification number;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(6)">(6)</span> Prescriber identification number;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(7)">(7)</span> Date prescription was issued by prescriber;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(8)">(8)</span> Date prescription was dispensed;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(9)">(9)</span> Prescription number;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(10)">(10)</span> Prescription type, whether the prescription is new or is a refill;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(11)">(11)</span> National Drug Code for the drug dispensed;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(12)">(12)</span> Quantity dispensed;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(13)">(13)</span> Number of days’ supply dispensed;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(14)">(14)</span> Number of refills ordered;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(15)">(15)</span> Source of payment for the prescription; and</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(c)(16)">(16)</span> Any other required information as specified in the regulations promulgated by the Director to implement this chapter, or as required for the Program to be eligible to receive federal funds.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(d)">(d)</span> Each dispenser shall transmit the required reporting information in accordance with the manner, format, standards, and schedules established by the Director through rulemaking.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(e)">(e)</span> The reporting requirements of this chapter shall not apply to the dispensing of covered substances when the dispensing is limited to the following:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(e)(1)">(1)</span> Administering covered substances;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(e)(2)">(2)</span> Dispensing covered substances within an appropriately licensed narcotic maintenance program;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(e)(3)">(3)</span> Dispensing covered substances to inpatients in hospitals or nursing facilities licensed by the Department or facilities that are otherwise authorized by law to operate as hospitals or nursing homes in the District;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(e)(4)">(4)</span> Dispensing covered substances to inpatients in hospices licensed by the Department; or</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03#(e)(5)">(5)</span> Dispensing covered substances as otherwise provided in the Department’s regulations.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66#§4" title="§ 4.">Feb. 22, 2014, D.C. Law 20-66, § 4, 61 DCR 7</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.03a" data-order="|48|8G|48-853.03a|" data-ref-path="§48-853.03a" class="h__section">§ 48–853.03a. Registration requirement for prescribers and dispensers. [Repealed]</h2>
                <p>Repealed.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66" title="D.C. Law 20-66. Prescription Drug Monitoring Program Act of 2013.">Feb. 22, 2014, D.C. Law 20-66, § 4a</a>; <a href="/us/dc/council/laws/22-288#§401(a)" title="">as added Apr. 11, 2019, D.C. Law 22-288, § 401(a), 66 DCR 1656</a>; <a href="/us/dc/council/laws/23-116#§4(a)" title="">June 24, 2020, D.C. Law 23-116, § 4(a), 67 DCR 5081</a>.)
    </p>
                  <h4>Emergency Legislation</h4>
                  <p>
                    <a class="internal-link" href="/us/dc/council/acts/23-112#§7168" title="§ 7168.">For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see <a class="internal-link " href="/us/dc/council/acts/23-112#§7168" title="§ 7168.">§ 7168 of Fiscal Year 2020 Budget Support Congressional Review Emergency Act of 2019 (D.C. Act 23-112, Sept. 4, 2019, 66 DCR 11964)</a>.</a>
                  </p>
                  <p>
                    <a class="internal-link" href="/us/dc/council/acts/23-91#§7168" title="§ 7168.">For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see <a class="internal-link " href="/us/dc/council/acts/23-91#§7168" title="§ 7168.">§ 7168 of Fiscal Year 2020 Budget Support Emergency Act of 2019 (D.C. Act 23-91, July 22, 2019, 66 DCR 8497)</a>.</a>
                  </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.03b" data-order="|48|8G|48-853.03b|" data-ref-path="§48-853.03b" class="h__section">§ 48–853.03b. Registration requirement for practitioners and dispensers.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03b#(a)">(a)</span> Any practitioner who is licensed, registered, or otherwise permitted to prescribe, distribute, dispense, conduct research with respect to, or to administer a controlled substance or other covered substance in the course of his or her professional practice, and any dispenser who is licensed in the District of Columbia to dispense a controlled substance or other covered substance to an ultimate user, the user's agent, or owner in the case of animals, shall be registered with the Program.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03b#(b)">(b)</span> Beginning 90 days afterJune 24, 2020, each practitioner or dispenser who is required to be registered with the Program, pursuant to subsection (a) of this section, shall register with the Program within 90 days of obtaining a new health professional license or before renewing an existing health professional license, whichever occurs first.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03b#(c)">(c)</span> The Health Occupations Boards shall not approve a practitioner or dispenser, who is required to be registered with the Program pursuant to subsection (a) of this section, for reinstatement, reactivation, or renewal of licensure without proof that the practitioner or dispenser has registered with the Program as required.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03b#(d)">(d)</span> Failure to timely register with the Program shall constitute grounds for disciplinary action by the relevant health occupations board pursuant to <a class="internal-link no-wrap" href="/us/dc/council/code/sections/3-1205.14#(c)" title="">§ 3-1205.14(c)</a>, and the imposition of civil fines pursuant to <a class="internal-link no-wrap" href="/us/dc/council/code/sections/2-1801.04" title="§ 2–1801.04. Monetary sanctions.">§ 2-1801.04</a>.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66" title="D.C. Law 20-66. Prescription Drug Monitoring Program Act of 2013.">Feb. 22, 2014, D.C. Law 20-66, § 4b</a>; <a href="/us/dc/council/laws/23-116#§4(b)" title="">as added June 24, 2020, D.C. Law 23-116, § 4(b), 67 DCR 5081</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.03c" data-order="|48|8G|48-853.03c|" data-ref-path="§48-853.03c" class="h__section">§ 48–853.03c. Database Query requirement for prescribers and dispensers.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(a)">(a)</span><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(a)(1)">(1)</span> Except as provided in subsection (c) of this section, a prescriber who is licensed, registered, or otherwise permitted to prescribe a controlled substance or other covered substance in the course of his or her professional practice in the District of Columbia, or the prescriber's authorized delegee, shall query the District of Columbia prescription drug monitoring database before initiating a new course of treatment or therapy for a patient in the District of Columbia that includes prescribing an opioid or benzodiazepine for more than 7 consecutive days, and every 90 days thereafter while the course of treatment or therapy continues.</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(a)(2)">(2)</span> Nothing in this subsection shall prohibit a prescriber from making additional periodic queries of the prescription drug monitoring program database as may be required by routine prescribing practices.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(b)">(b)</span><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(b)(1)">(1)</span> Except as provided in subsection (c) of this section, a dispenser who is licensed, registered, or otherwise permitted to dispense a controlled substance or other covered substance in the course of his or her professional practice in the District of Columbia, or the dispenser's authorized delegee, shall query the District of Columbia prescription drug monitoring database before dispensing an opioid or benzodiazepine for a course of treatment that is anticipated to last for more than 7 consecutive days, and before dispensing a refill for an opioid or benzodiazepine more than 90 days after the initial fill or previous refill date.</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(b)(2)">(2)</span> Nothing in this section shall prohibit a dispenser from making additional periodic queries of the prescription drug monitoring program database as may be required by routine prescribing practices.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(c)">(c)</span> A prescriber or dispenser shall not be required to meet the provisions of subsection (a) or (b) of this section if the:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(c)(1)">(1)</span> Controlled substance or other covered substance is prescribed or otherwise provided to a patient currently receiving hospice or palliative care;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(c)(2)">(2)</span> Controlled substance or other covered substance is prescribed or otherwise provided to a patient during an inpatient hospital admission or at discharge;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(c)(3)">(3)</span> Controlled substance or other covered substance is prescribed or otherwise provided to a patient in a nursing home or residential care facility that uses a sole source pharmacy;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(c)(4)">(4)</span> Prescription drug monitoring program database is not operational or available due to a temporary technological or electrical failure or natural disaster; or</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(c)(5)">(5)</span> Prescriber or dispenser is unable to access the prescription drug monitoring program database due to an emergency or a disaster and documents the circumstances in the patient's medical record.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.03c#(d)">(d)</span> Failure to comply with the provisions of this section shall constitute grounds for disciplinary action by the relevant health occupations board pursuant to <a class="internal-link no-wrap" href="/us/dc/council/code/sections/3-1205.14#(c)" title="">§ 3-1205.14(c)</a> and the imposition of civil fines pursuant to <a class="internal-link no-wrap" href="/us/dc/council/code/sections/2-1801.04" title="§ 2–1801.04. Monetary sanctions.">§ 2-1801.04</a>.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66" title="D.C. Law 20-66. Prescription Drug Monitoring Program Act of 2013.">Feb. 22, 2014, D.C. Law 20-66, § 4c</a>; <a href="/us/dc/council/laws/23-251#§101" title="§ 101.">as added Mar. 16, 2021, D.C. Law 23-251, § 101, 68 DCR 001234</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.04" data-order="|48|8G|48-853.04|" data-ref-path="§48-853.04" class="h__section">§ 48–853.04. Authority to access database.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.04#(a)">(a)</span> A prescriber or dispenser authorized to access the information in the possession of the Program pursuant to this chapter may delegate, pursuant to regulations promulgated by the Director to implement the provisions of this section, such authority to up to 2 health care professionals who are:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.04#(a)(1)">(1)</span> Licensed, registered, or certified by a health occupations board; and</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.04#(a)(2)">(2)</span> Employed at the same facility and under the direct supervision of the prescriber or dispenser.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.04#(b)">(b)</span> No prescriber or dispenser shall provide false or misleading information to the Department with the intent to obtain unauthorized access to, or alter the information in the possession of the Program.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.04#(c)">(c)</span> A violation of subsection (b) of this section shall constitute grounds for:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.04#(c)(1)">(1)</span> The revocation, suspension, or denial of a District controlled substances registration;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.04#(c)(2)">(2)</span> Disciplinary action by the relevant health occupations board pursuant to <a class="internal-link no-wrap" href="/us/dc/council/code/sections/3-1205.14#(c)" title="">§ 3-1205.14(c)</a>; and</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.04#(c)(3)">(3)</span> The imposition of civil fines pursuant to <a class="internal-link no-wrap" href="/us/dc/council/code/sections/2-1801.04" title="§ 2–1801.04. Monetary sanctions.">§ 2-1801.04</a>.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66#§5" title="§ 5.">Feb. 22, 2014, D.C. Law 20-66, § 5, 61 DCR 7</a>; <a href="/us/dc/council/laws/22-288#§401(b)" title="">Apr. 11, 2019, D.C. Law 22-288, § 401(b), 66 DCR 1656</a>.)
    </p>
                  <h4>Emergency Legislation</h4>
                  <p>
                    <a class="internal-link" href="/us/dc/council/acts/23-112#§7168" title="§ 7168.">For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see <a class="internal-link " href="/us/dc/council/acts/23-112#§7168" title="§ 7168.">§ 7168 of Fiscal Year 2020 Budget Support Congressional Review Emergency Act of 2019 (D.C. Act 23-112, Sept. 4, 2019, 66 DCR 11964)</a>.</a>
                  </p>
                  <p>
                    <a class="internal-link" href="/us/dc/council/acts/23-91#§7168" title="§ 7168.">For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see <a class="internal-link " href="/us/dc/council/acts/23-91#§7168" title="§ 7168.">§ 7168 of Fiscal Year 2020 Budget Support Emergency Act of 2019 (D.C. Act 23-91, July 22, 2019, 66 DCR 8497)</a>.</a>
                  </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.05" data-order="|48|8G|48-853.05|" data-ref-path="§48-853.05" class="h__section">§ 48–853.05. Confidentiality of data; disclosure of information; discretionary authority of the Director.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(a)">(a)</span> All data, records, and reports relating to the prescribing and dispensing of covered substances to patients and any abstracts from such data, records, and reports that are in the possession of the Program pursuant to this chapter and any materials relating to the operation or safety of the Program shall be confidential and shall be exempt from disclosure based on requests made pursuant to <a class="internal-link " href="/us/dc/council/code/titles/2/chapters/5/subchapters/II" title="Subchapter II. Freedom of Information.">subchapter II of Chapter 5 of Title 2</a> [<a class="internal-link no-wrap" href="/us/dc/council/code/sections/2-531" title="§ 2–531. Public policy.">§ 2-531</a> et seq.]. Information obtained pursuant to the Program may only be disclosed as provided in this chapter.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(b)">(b)</span> Upon receiving a request for information in accordance with the Department’s regulations and in compliance with applicable District and federal laws and regulations, the Director shall disclose information relevant to:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(b)(1)">(1)</span> A specific investigation of a specific patient or of a specific dispenser or prescriber to an agent designated by the Chief of the Metropolitan Police Department to conduct drug diversion investigations;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(b)(2)">(2)</span> An investigation or inspection of or allegation of misconduct by a specific person licensed, certified, or registered by or an applicant for licensure, certification, or registration by a health occupations board or the Department;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(b)(3)">(3)</span> A disciplinary proceeding before a health occupations board or in any subsequent hearing, trial, or appeal of an action or board order to designated employees of the Department;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(b)(4)">(4)</span> The proceedings of any grand jury or additional grand jury that has been properly impaneled in accordance with <a class="internal-link no-wrap" href="/us/dc/council/code/sections/11-1916" title="§ 11–1916. Grand jury; additional grand jury.">§ 11-1916</a>; and</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(b)(5)">(5)</span> A specific investigation of a specific patient or of a specific dispenser or prescriber to an agent of a federal law-enforcement agency with authority to conduct drug diversion investigations.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)">(c)</span><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(1)">(1)</span> In accordance with the Department’s regulations and applicable federal law and regulations, the Director may, at the Director’s discretion, disclose:</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(1)(A)">(A)</span> Information in the possession of the Program concerning a patient who is over the age of 18 years to that patient, or to the parent or legal guardian of a child aged 18 years or under, unless otherwise prohibited by District or federal law;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(1)(B)">(B)</span> Information on a specific patient to a prescriber for the purpose of establishing the treatment history of the specific patient when the patient is either under care and treatment by the prescriber or the prescriber is initiating treatment of the patient;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(1)(C)">(C)</span> Information on a specific patient to a dispenser for the purpose of establishing a prescription history to assist the dispenser in determining the validity of a prescription when the patient is seeking a covered substance from the dispenser or the facility in which the dispenser practices;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(1)(D)">(D)</span> Information relevant to an investigation or regulatory proceeding of a specific dispenser or prescriber to other regulatory authorities concerned with granting, limiting, or denying licenses, certificates, or registrations to practice a health profession when the regulatory authority licenses the dispenser or prescriber, or the dispenser or prescriber is seeking licensure by a regulatory authority;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(1)(E)">(E)</span> Information relevant to an investigation relating to a specific dispenser or prescriber who is a participating provider in the District Medicaid program, DC Health Care Alliance, or any other public health care program; information relating to an investigation relating to a specific patient who is currently eligible for and receiving, or who has been eligible for and has received medical assistance services; information relevant to the Medicaid Fraud Control Unit of the Office of the Inspector General, or to designated employees of the Department of Health Care Finance, as appropriate;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(1)(F)">(F)</span> Information relevant to the determination of the cause of death of a specific patient to the designated employees of the Office of the Chief Medical Examiner; and</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(1)(G)">(G)</span> Information for the purpose of bona fide research or education to qualified personnel; provided, that:</p>
                <p class="text-indent-4"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(1)(G)(i)">(i)</span> Data elements that would reasonably identify a specific patient, prescriber, or dispenser shall be deleted or redacted from the information before disclosure; and</p>
                <p class="text-indent-4"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(1)(G)(ii)">(ii)</span> Release of the information shall only be made pursuant to a written agreement between qualified personnel and the Director to ensure compliance with this chapter.</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(2)">(2)</span> For the purposes of a disclosure under paragraph (1)(B) or (C) of this subsection:</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(2)(A)">(A)</span> The request shall be made and the information shall be provided in the manner specified by the Director through rulemaking; and</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(c)(2)(B)">(B)</span> Notice shall be given to patients that the information described in paragraph (1)(B) or (C) of this subsection, as applicable, may be requested by a prescriber or dispenser participating with the Program.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.05#(d)">(d)</span> Confidential information that has been received, maintained, or developed by a health occupations board or disclosed by the health occupations board pursuant to this chapter shall not be available for discovery or court subpoena or introduced into evidence in any medical malpractice suit or other action for damages arising out of the provision of or failure to provide services; provided, that this section shall not be construed to inhibit any investigation or prosecution conducted pursuant to this chapter.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66#§6" title="§ 6.">Feb. 22, 2014, D.C. Law 20-66, § 6, 61 DCR 7</a>; <a href="/us/dc/council/laws/22-288#§401(c)" title="">Apr. 11, 2019, D.C. Law 22-288, § 401(c), 66 DCR 1656</a>.)
    </p>
                  <h4>Section References</h4>
                  <p>This section is referenced in <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-853.02" title="§ 48–853.02. Program establishment; Director’s authority.">§ 48-853.02</a>.</p>
                  <h4>Emergency Legislation</h4>
                  <p>
                    <a class="internal-link" href="/us/dc/council/acts/23-112#§7168" title="§ 7168.">For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see <a class="internal-link " href="/us/dc/council/acts/23-112#§7168" title="§ 7168.">§ 7168 of Fiscal Year 2020 Budget Support Congressional Review Emergency Act of 2019 (D.C. Act 23-112, Sept. 4, 2019, 66 DCR 11964)</a>.</a>
                  </p>
                  <p>
                    <a class="internal-link" href="/us/dc/council/acts/23-91#§7168" title="§ 7168.">For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see <a class="internal-link " href="/us/dc/council/acts/23-91#§7168" title="§ 7168.">§ 7168 of Fiscal Year 2020 Budget Support Emergency Act of 2019 (D.C. Act 23-91, July 22, 2019, 66 DCR 8497)</a>.</a>
                  </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.06" data-order="|48|8G|48-853.06|" data-ref-path="§48-853.06" class="h__section">§ 48–853.06. Interoperability; information exchange with other prescription drug monitoring programs.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.06#(a)">(a)</span> The Director may enter into written agreements with other prescription drug monitoring programs, or a third party, approved by the Director, that operates an interstate prescription drug monitoring exchange, for the purpose of interoperability and the mutual exchange of information among prescription drug monitoring programs, and describing the terms and conditions for the sharing of prescription information under this section.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.06#(b)">(b)</span> The Director may provide prescription monitoring information pursuant to such agreements, which shall only use the information for the purposes allowed by this chapter.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.06#(c)">(c)</span> The Director may request and receive prescription drug monitoring information from other states’ prescription drug monitoring programs and may use the information under the provisions of this chapter.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66#§7" title="§ 7.">Feb. 22, 2014, D.C. Law 20-66, § 7, 61 DCR 7</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.07" data-order="|48|8G|48-853.07|" data-ref-path="§48-853.07" class="h__section">§ 48–853.07. Criteria for indicators of misuse; Director’s authority to disclose information; intervention.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(a)">(a)</span> The Director may establish through rulemaking:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(a)(1)">(1)</span> Criteria for indicators of misuse or abuse of covered substances;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(a)(2)">(2)</span> A method for analysis of data collected by the Program using the criteria for indicators of misuse or abuse of covered substances;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(a)(3)">(3)</span> Criteria for indications of a possible violation of law or a possible breach of professional standards by a prescriber or dispenser; and</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(a)(4)">(4)</span> A method for analysis of data collected by the Program using the criteria for indications of a possible violation of law or a possible breach of professional standards by a prescriber or dispenser.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(b)">(b)</span><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(b)(1)">(1)</span> Upon the development of the criteria and data analysis, the Program may review prescription monitoring program data for indications of:</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(b)(1)(A)">(A)</span> Possible misuse or abuse of a covered prescription drug; and</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(b)(1)(B)">(B)</span> A possible violation of law or possible breach of professional standards by a prescriber or a dispenser.</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(b)(2)">(2)</span> If the Program's review of prescription monitoring data indicates a possible violation of paragraph (1) of this subsection, the Director may, in addition to any discretionary disclosure of information pursuant to <a class="internal-link no-wrap" href="/us/dc/council/code/titles/48/chapters/8G" title="Chapter 8G. Prescription Drug Monitoring.">this chapter</a>:</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(b)(2)(A)">(A)</span> Report the possible misuse or abuse by a patient to the specific prescriber or dispenser of the covered prescription drug for the purpose of intervention to prevent such misuse or abuse;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(b)(2)(B)">(B)</span> Notify the prescriber or dispenser of the possible violation of law or possible breach of professional standards; and</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-853.07#(b)(2)(C)">(C)</span> Provide education to the prescriber or dispenser.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66#§8" title="§ 8.">Feb. 22, 2014, D.C. Law 20-66, § 8, 61 DCR 7</a>; <a href="/us/dc/council/laws/22-288#§401(d)" title="">Apr. 11, 2019, D.C. Law 22-288, § 401(d), 66 DCR 1656</a>.)
    </p>
                  <h4>Emergency Legislation</h4>
                  <p>
                    <a class="internal-link" href="/us/dc/council/acts/23-112#§7168" title="§ 7168.">For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see <a class="internal-link " href="/us/dc/council/acts/23-112#§7168" title="§ 7168.">§ 7168 of Fiscal Year 2020 Budget Support Congressional Review Emergency Act of 2019 (D.C. Act 23-112, Sept. 4, 2019, 66 DCR 11964)</a>.</a>
                  </p>
                  <p>
                    <a class="internal-link" href="/us/dc/council/acts/23-91#§7168" title="§ 7168.">For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see <a class="internal-link " href="/us/dc/council/acts/23-91#§7168" title="§ 7168.">§ 7168 of Fiscal Year 2020 Budget Support Emergency Act of 2019 (D.C. Act 23-91, July 22, 2019, 66 DCR 8497)</a>.</a>
                  </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.08" data-order="|48|8G|48-853.08|" data-ref-path="§48-853.08" class="h__section">§ 48–853.08. Immunity from liability.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.08#(a)">(a)</span> The Director and the employees of the Department shall not be liable for any civil damages resulting from the accuracy or inaccuracy of any information reported, compiled, or maintained by the Program pursuant to this chapter.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.08#(b)">(b)</span> The Director and the employees of the Department shall not be liable for any civil damages resulting from the disclosure of or failure to disclose any information in compliance with this chapter and the Department’s regulations.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.08#(c)">(c)</span> In the absence of gross negligence or willful misconduct, prescribers or dispensers complying in good faith with the reporting requirements of this chapter shall not be liable for any civil damages for any act or omission resulting from the submission of such required reports.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66#§9" title="§ 9.">Feb. 22, 2014, D.C. Law 20-66, § 9, 61 DCR 7</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.09" data-order="|48|8G|48-853.09|" data-ref-path="§48-853.09" class="h__section">§ 48–853.09. Unlawful disclosure of information and acts; disciplinary action authorized; penalties.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.09#(a)">(a)</span> It shall be unlawful for any person having access to the confidential information in possession of the Program or any data or reports produced by the Program to disclose the confidential information except as provided in this chapter. Any person who discloses this confidential information in violation of the provisions of this chapter shall be guilty of a misdemeanor upon conviction.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.09#(b)">(b)</span> It shall be unlawful for any person who lawfully receives confidential information from the Program to redisclose or use the confidential information in any way other than the authorized purpose for which the request was made. Any person who discloses confidential information in violation of this chapter shall be guilty of a misdemeanor upon conviction.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.09#(c)">(c)</span> Nothing in this section shall prohibit a person who prescribes or dispenses a covered substance required to be reported to the program from redisclosing information obtained from the Program to another prescriber or dispenser who has prescribed or dispensed a covered substance to the same patient.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-853.09#(d)">(d)</span> Unauthorized use or disclosure of confidential information received from the Program shall also be grounds for disciplinary action by the relevant health occupations board.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66#§10" title="§ 10.">Feb. 22, 2014, D.C. Law 20-66, § 10, 61 DCR 7</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-853.10" data-order="|48|8G|48-853.10|" data-ref-path="§48-853.10" class="h__section">§ 48–853.10. Rules.</h2>
                <p>The Director, pursuant <a class="internal-link " href="/us/dc/council/code/titles/2/chapters/5/subchapters/I" title="Subchapter I. Administrative Procedure.">subchapter I of Chapter 5 of Title 2</a> [<a class="internal-link no-wrap" href="/us/dc/council/code/sections/2-501" title="§ 2–501. Effect of subchapter.">§ 2-501</a> et seq.], shall issue rules to implement the provisions of this chapter, including the establishment of criteria for granting waivers to the reporting requirements set forth in this chapter.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/20-66#§11" title="§ 11.">Feb. 22, 2014, D.C. Law 20-66, § 11, 61 DCR 7</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__us-dc" aria-label="Previous and next article links">
            <section>
              <a href="/us/dc/council/code/titles/48/chapters/8F" aria-label="Chapter 8F. Safe Disposal of Unused Pharmaceuticals.">
                <div class="h__ui">Previous</div>
                <span>Chapter 8F. Safe Disposal of Unused Pharmaceuticals.</span>
              </a>
            </section>
            <section>
              <a href="/us/dc/council/code/titles/48/chapters/8H" aria-label="Chapter 8H. Specialty Drug Copayment Limitation.">
                <div class="h__ui">Next</div>
                <span>Chapter 8H. Specialty Drug Copayment Limitation.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__us-dc">
        <div id="section__footer__inner" class="ns__document__us-dc">
          <section id="area__footer__logo" class="ns__document__us-dc">
            <a href="/" class="logo" aria-label="Logo - Return to home page">
              <img src="/us/dc/_document/v2/images/logo/dc-seal.png" srcset="/us/dc/_document/v2/images/logo/dc-seal.png 1x, /us/dc/_document/v2/images/logo/dc-seal@2x.png 2x" alt="Council of the District of Columbia logo"/>
            </a>
          </section>
          <div id="area__footer__content" class="ns__document__us-dc">
            <p>The codes and laws on this website are in the public domain.</p>
            <p>
      Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/law-html">HTML</a> or <a href="https://github.com/dccouncil/law-xml">XML</a>.
    </p>
            <p>Powered by the non-profit <a href="http://www.openlawlib.org/">Open Law Library</a>.</p>
          </div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
